- MEDIUM
- Research
- Tier 1
- Hard News
NIH awards $3.2M multi-institutional grant to study new oral cancer treatment
- Source
- Becker's Dental + DSO Review
- Author
- Cameron Cortigiano
- Originally at
- beckersdental.com(opens in a new tab)
Summary and scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol. Not the original publisher.
Why it matters for dental
NIH funding for an injectable hydrogel that delivers oral-cancer immunotherapy could eventually change treatment protocols for oral malignancies handled by oral surgeons and head-and-neck specialists.
Key points
- 01
National Institute of Dental and Craniofacial Research awarded a $3.24 million grant to test the SABERGel injectable biomaterial.
- 02
Simon Young (UTHealth Houston School of Dentistry), Jeffrey Hartgerink (Rice University), and Andrew Sikora (UT MD Anderson Cancer Center) are the co-principal investigators.
- 03
The five-year project is scheduled to run through June 2031 and will seek to identify promising hydrogel formulations.
- 04
The research aims to generate preclinical evidence that could guide further development toward potential testing in patients.
Who should care
- Specialist
- Academia / research
Read the original
Becker's Dental + DSO Review
Full reporting and any paywalled content live on beckersdental.com. We summarize and score; we do not republish.